F C Jolicoeur

643 total citations
9 papers, 527 citations indexed

About

F C Jolicoeur is a scholar working on Rheumatology, Pharmacology and Molecular Biology. According to data from OpenAlex, F C Jolicoeur has authored 9 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in F C Jolicoeur's work include Inflammatory mediators and NSAID effects (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). F C Jolicoeur is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). F C Jolicoeur collaborates with scholars based in Canada, Japan and Germany. F C Jolicoeur's co-authors include Johanne Martel‐Pelletier, François Mineau, Jean‐Pierre Pelletier, Dragan Jovanović, J.-P. Pelletier, J M Cloutier, John A. Di Battista, Johanne Martel‐Pelletier, Mohamed Benderdour and Pascal Reboul and has published in prestigious journals such as Osteoarthritis and Cartilage, Molecular and Cellular Endocrinology and Arthritis & Rheumatism.

In The Last Decade

F C Jolicoeur

9 papers receiving 507 citations

Peers

F C Jolicoeur
Marcia L. Bliven United States
C Curtis United Kingdom
Yun‐Ju Woo South Korea
Jimin Jeon South Korea
C. Alander United States
H Hojo Japan
Marcia L. Bliven United States
F C Jolicoeur
Citations per year, relative to F C Jolicoeur F C Jolicoeur (= 1×) peers Marcia L. Bliven

Countries citing papers authored by F C Jolicoeur

Since Specialization
Citations

This map shows the geographic impact of F C Jolicoeur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F C Jolicoeur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F C Jolicoeur more than expected).

Fields of papers citing papers by F C Jolicoeur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F C Jolicoeur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F C Jolicoeur. The network helps show where F C Jolicoeur may publish in the future.

Co-authorship network of co-authors of F C Jolicoeur

This figure shows the co-authorship network connecting the top 25 collaborators of F C Jolicoeur. A scholar is included among the top collaborators of F C Jolicoeur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F C Jolicoeur. F C Jolicoeur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lavigne, Patrick, Qin Shi, F C Jolicoeur, et al.. (2002). Modulation of IL-1β, IL-6, TNF-α and PGE2 by pharmacological agents in explants of membranes from failed total hip replacement. Osteoarthritis and Cartilage. 10(11). 898–904. 20 indexed citations
2.
Jovanović, Dragan, Julio Fernandes, Johanne Martel-Pelletier, et al.. (2001). In vivo dual inhibition of cyclooxygenase and lipoxygenase by ML-3000 reduces the progression of experimental osteoarthritis: Suppression of collagenase 1 and interleukin-1? synthesis. Arthritis & Rheumatism. 44(10). 2320–2330. 85 indexed citations
3.
Jovanović, Dragan, John A. Di Battista, Johanne Martel‐Pelletier, et al.. (2001). Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.. PubMed. 28(4). 712–8. 38 indexed citations
4.
Moldovan, Florina, Jean‐Pierre Pelletier, F C Jolicoeur, J M Cloutier, & Johanne Martel‐Pelletier. (2000). Diacerhein and rhein reduce the ICE-induced IL-1β and IL-18 activation in human osteoarthritic cartilage. Osteoarthritis and Cartilage. 8(3). 186–196. 74 indexed citations
5.
Jovanović, Dragan, Johanne Martel‐Pelletier, John A. Di Battista, et al.. (2000). Stimulation of 92‐kd gelatinase (matrix metalloproteinase 9) production by interleukin‐17 in human monocyte/macrophages: A possible role in rheumatoid arthritis. Arthritis & Rheumatism. 43(5). 1134–1144. 147 indexed citations
6.
Pelletier, J.-P., Daniel Lajeunesse, V. Lascau-Coman, et al.. (2000). Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis.. PubMed. 27(12). 2893–902. 60 indexed citations
7.
Martel‐Pelletier, Johanne, François Mineau, F C Jolicoeur, J M Cloutier, & J.-P. Pelletier. (1998). In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes.. PubMed. 25(4). 753–62. 80 indexed citations
8.
Ounissi‐Benkalha, Houria, J.-P. Pelletier, Ginette Tardif, et al.. (1996). In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis.. PubMed. 23(1). 16–23. 13 indexed citations
9.
DiBattista, John A., Johanne Martel‐Pelletier, Nathalie Morin, F C Jolicoeur, & Jean‐Pierre Pelletier. (1994). Transcriptional regulation of plasminogen activator inhibitor-1 expression in human synovial fibroblasts by prostaglandin E2: mediation by protein kinase A and role of interleukin-1. Molecular and Cellular Endocrinology. 103(1-2). 139–148. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026